Anant Labs

Etravirine

CAS 269055-15-4

Overview

Etravirine is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor. Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etravirine. Etravirine is marketed by Tibotec, a subsidiary of Johnson & Johnson.

Anant Labs manufacture and furnish high quality Etravirine impurities for global markets. Our Etravirine EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Etravirine
In Stock

Etravirine

CAS 269055-15-4In Stock
WhatsApp
Technical Data
CAS269055-15-4
Mol. FormulaC20H15BrN6O
Mol. Weight435.285 g/mol
IUPAC4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile
SMILESCC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N
InChIInChI=1S/C20H15BrN6O/c1-11-7-14(10-23)8-12(2)17(11)28-19-16(21)18(24)26-20(27-19)25-15-5-3-13(9-22)4-6-15/h3-8H,1-2H3,(H3,24,25,26,27)
InChI KeyPYGWGZALEOIKDF-UHFFFAOYSA-N

Note: We are upgrading our system, Cat No will change.

Synonyms
Etravirine269055-15-4IntelenceTMC-125TMC125TMC 125R165335R-1653354-((6-Amino-5-bromo-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrileEtravirina

Looking for a specific reference standard?

Tell us what you need. Our team responds within one business day.